share_log
Breakings ·  Dec 12 21:55
Iteos Therapeutics Presents Interim a2a-005 Clinical Trial Data, Translational, and Preclinical Data From Inupadenant at Esmo Immuno-Oncology Congress
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment